Premium Nahrungsergänzungsmittel | artgerecht

Palmitoylethanolamide (PEA) – Effects and Uses

Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide produced by the human body, known for its anti-inflammatory and pain-relieving properties. It is widely used as a dietary supplement and in pain management.

Regular tips about health Regular tips about health

Things worth knowing about "Palmitoylethanolamide (PEA)"

Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide produced by the human body, known for its anti-inflammatory and pain-relieving properties. It is widely used as a dietary supplement and in pain management.

What is Palmitoylethanolamide (PEA)?

Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide belonging to the family of endocannabinoid-related lipid mediators. It is synthesized endogenously from palmitic acid and ethanolamine and is found in various tissues and organs throughout the body. First discovered in the 1950s, PEA has since been extensively studied for its biological and therapeutic properties.

PEA is also present in small amounts in everyday foods such as egg yolk, soybeans, peanuts, and meat. As a dietary supplement, it is commonly available in micronized or ultramicronized form to enhance bioavailability and absorption.

Mechanism of Action

PEA exerts its effects through several molecular mechanisms:

PPAR-alpha activation: PEA binds to the peroxisome proliferator-activated receptor alpha (PPAR-alpha), a nuclear receptor that regulates anti-inflammatory signaling pathways and suppresses the expression of pro-inflammatory genes.
Mast cell stabilization: PEA inhibits the degranulation of mast cells, thereby reducing the release of inflammatory mediators such as histamine and cytokines.
Modulation of the endocannabinoid system: PEA indirectly increases the availability of anandamide (an endogenous cannabinoid) by inhibiting its degrading enzymes -- an effect known as the entourage effect.
GPR55 and GPR119 activation: PEA interacts with G-protein-coupled receptors, influencing neuroprotective and antinociceptive (pain-reducing) signaling pathways.

Medical Applications

PEA is used in medicine and as a dietary supplement for a range of indications:

Chronic pain: PEA is primarily used for chronic pain conditions including neuropathies, fibromyalgia, sciatica, and other pain syndromes.
Inflammatory conditions: Due to its anti-inflammatory properties, PEA is applied in conditions such as endometriosis, irritable bowel syndrome, and osteoarthritis.
Neurological disorders: Emerging evidence suggests neuroprotective effects in conditions such as multiple sclerosis and Alzheimer's disease.
Allergic conditions: PEA may help dampen mast cell activity in allergic reactions and atopic conditions such as eczema.

Dosage and Usage

Clinical studies have typically used the following dosage ranges:

Standard PEA: 300 mg to 1200 mg per day, divided into 2-3 doses.
Micronized or ultramicronized PEA (m-PEA / um-PEA): These forms offer improved solubility and bioavailability and are often used at lower doses (e.g., 600 mg/day).

PEA is typically taken orally. Since the substance is lipophilic (fat-soluble), it is recommended to take it with a fatty meal to enhance absorption.

Safety and Side Effects

PEA is generally considered safe and well-tolerated. No serious adverse effects have been reported in clinical studies. Occasional mild side effects may include:

Mild gastrointestinal discomfort (nausea, bloating)
Drowsiness at higher doses

As PEA is an endogenous substance, no addiction potential is known. Drug interactions are largely undocumented, though caution is advised when combining PEA with anticoagulants or other lipid-active substances. Pregnant and breastfeeding individuals should consult a healthcare professional before use.

Scientific Evidence

The body of scientific evidence supporting PEA has grown substantially in recent years. Numerous randomized controlled trials and meta-analyses support the efficacy of PEA in neuropathic pain and inflammatory conditions. A meta-analysis published in 2016 by Paladini et al. demonstrated that PEA can achieve significant pain reductions across various pain syndromes. However, further large-scale clinical trials are needed to fully confirm its efficacy for specific conditions.

References

Paladini A. et al. - Palmitoylethanolamide, a Special Food for Medical Purposes, in the Treatment of Chronic Pain: A Pooled Data Meta-analysis. Pain Physician, 2016.
Gabrielsson L. et al. - Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. British Journal of Clinical Pharmacology, 2016.
Petrosino S., Di Marzo V. - The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. British Journal of Pharmacology, 2017.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.